ABC | Volume 111, Nº1, July 2018

Original Article Bassi et al T2DM and HTN on HRV and cardiorespiratory status Arq Bras Cardiol. 2018; 111(1):64-72 This is an open-access article distributed under the terms of the Creative Commons Attribution License 28. Guazzi M, Arena R. CardioPulse. New clinical cardiopulmonary exercise testing joint statement from the European Society of Cardiology and American Heart Association. Eur Heart J. 2012;33(21):2627-8. 29. Taylor R. Interpretation of the correlation coefficient: a basic review. J Diagnostic Med Sonogr. 1990;6(1):35-9. 30. Takahashi N, Nakagawa M, Saikawa T, Ooie T, Yufu K, Shigematsu S, et al. Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients. J Am Coll Cardiol. 2001;38(1):232-7. 31. BassiD,ArakelianVM,MendesRG,CarusoFC,BonjornoJúniorJC,Zangrando KT,etal.Poorglycemiccontrolimpacts linearandnon-lineardynamicsofheart rate in DM type 2. Rev Bras Med Esporte. 2015;21(4):313-7. 32. Schroeder EB, Liao D, Chambless LE, Prineas RJ, Evans GW, Heiss G. Hypertension, blood pressure, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Hypertension. 2003;42(6):1106-11. 33. Forsblom CM, Sane T, Groop PH, Tötterman KJ, Kallio M, Saloranta C, et al. Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia. 1998;41(11):1253-62. 34. Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol. 2010;141(2):122-31. 35. Cambri LT, Oliveira FR de, GevaerdMda S. Cardiac autonomicmodulation in rest and metabolic control in subjects with type 2 diabetes. HU Revista, Juiz de Fora. 2008;34(2):115-21. 36. Roy B, Ghatak S. Nonlinearmethods to assess changes in heart rate variability in type 2 diabetic patients. Arq Bras Cardiol. 2013;101(4):317-27. 37. Ding W, Zhou L, Bao Y, Zhou L, Yang Y, Lu B, et al. Autonomic nervous function and baroreflex sensitivity in hypertensive diabetic patients. Acta Cardiol. 2011;66(4):465-70. 38. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115(3):387-97. 39. Pantoni CB, Mendes RG, Di Thommazo-Luporini L, Simões RP, Amaral-Neto O, Arena R, et al. Recovery of linear and nonlinear heart rate dynamics after coronary artery bypass grafting surgery. Clin Physiol Funct Imaging. 2014;34(6):449-56. 40. Voss A, Schulz S, Schroeder R, Baumert M, Caminal P. Methods derived from nonlinear dynamics for analysing heart rate variability. Philos Trans A Math Phys Eng Sci. 2009;367(1887):277-96. 41. Park YS, Hoh JK. Complex and irregular heart rate dynamics in fetuses compromised by maternal anemia as a high-risk pregnancy. J Perinat Med. 2015;43(6):741-8. 42. Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, et al; Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329(14):977-86. 43. Burger AJ, Weinrauch LA, D’Elia JA, Aronson D. Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy. Am J Cardiol. 1999;84(6):687-91. 44. Corrà U, Mezzani A, Giordano A, Bosimini E, Giannuzzi P. Exercise haemodynamic variables rather than ventilatory efficiency indexes contribute to risk assessment in chronic heart failure patients treated with carvedilol. Eur Heart J. 2009;30(24):3000-6. 45. Ugur-Altun B, Altun A, Tatli E, Arikan E, Tugrul A. Relationship between insulin resistance assessed by HOMA-IR and exercise test variables in asymptomatic middle-aged patients with type 2 diabetes. J Endocrinol Invest. 2004;27(5):455-61. 46. LangCC,KarlinP,Haythe J,LimTK,ManciniDM.Peakcardiacpoweroutput, measured noninvasively, is a powerful predictor of outcome in chronic heart failure. Circ Heart Fail. 2009;2(1):33-8. 72